Staphylococcus aureus With Reduced Vancomycin Susceptibility: Diagnostic Challenges in Clinical Settings
Vancomycin-intermediate <i>Staphylococcus aureus</i> (VISA) and vancomycin-resistant <i>S. aureus</i> (VRSA) have become significant challenges in treating staphylococcal infections, especially in areas...
